Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
2021 · The Lancet Oncology · 282 citations
https://doi.org/10.1016/s1470-2045(21)00493-9
A
Amrita Gaurav
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
87
Papers
664
Citations
12
h-index
13
i10-index
Amrita Gaurav is an academic researcher from All India Institute of Medical Sciences Rishikesh. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & Cervical Cancer and HPV Research & Endometrial and Cervical Cancer Treatments. The author has an h-index of 12, co-authored 74 publications.
ORCID: 0000-0002-8672-2463Papers by this author
worksOutcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer study
2022 · American Journal of Obstetrics and Gynecology · 58 citations
https://doi.org/10.1016/j.ajog.2022.06.052
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · The Lancet Diabetes & Endocrinology · 36 citations
https://doi.org/10.1016/s2213-8587(23)00253-x
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024 · The Lancet Child & Adolescent Health · 33 citations
https://doi.org/10.1016/s2352-4642(23)00316-4
Unidirectional Barbed Suture Versus Polyglactin 910 Suture for Vaginal Cuff Closure in Total Laparoscopic Hysterectomy
2021 · Cureus · 10 citations
https://doi.org/10.7759/cureus.14257
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · The Lancet Infectious Diseases · 5 citations
https://doi.org/10.1016/s1473-3099(25)00093-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat